Literature DB >> 12457461

Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads.

Mingui Fu1, Jifeng Zhang, Yimin Lin, Xiaojun Zhu, Luning Zhao, Mushtaq Ahmad, Markus U Ehrengruber, Yuqing E Chen.   

Abstract

Transforming growth factor beta (TGF beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) play major roles in the development of vascular diseases. It has been documented that PPAR gamma activation inhibits the TGF beta signal pathway in vascular smooth muscle cells (VSMC). Here we examined whether TGF beta can regulate PPAR gamma expression. Northern blot analyses revealed that both TGF beta 1 and 2 exert a biphasic effect (early stimulation and late repression) on PPAR gamma gene expression in VSMC. TGF beta rapidly and transiently induced early growth-response factor-1 (Egr-1) expression through the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 (MEK1)/ERK-mediated pathway. Inhibition of MEK1/ERK by PD98059 not only abrogated the induction of Egr-1 but also abolished the rapid and transient induction of PPAR gamma by TGF beta. Furthermore, overexpression of NAB2, a repressor of Egr-1 activation, also blocked the induction of PPAR gamma by TGF beta in VSMC, suggesting that Egr-1 mediates the rapid and transient induction of PPAR gamma by TGF beta. With regard to the TGF beta repression of PPAR gamma expression, activator protein 1 (AP1) and Smad3/4 dramatically inhibited the PPAR gamma promoter activity in transient-transfection studies. In contrast, adenovirus-mediated overexpression of a dominant-negative form of c-Jun partially rescued the TGF beta-induced PPAR gamma repression in VSMC. Taken together, our data demonstrate that Egr-1, AP1 and Smad are part components of the TGF beta signal transduction pathway that regulates PPAR gamma expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12457461      PMCID: PMC1223218          DOI: 10.1042/BJ20021503

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

Review 1.  CREB-binding protein and p300 in transcriptional regulation.

Authors:  N Vo; R H Goodman
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 2.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

3.  Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma.

Authors:  J Han; D P Hajjar; J M Tauras; J Feng; A M Gotto; A C Nicholson
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

Review 4.  TGF-betas and TGF-beta receptors in atherosclerosis.

Authors:  T A McCaffrey
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

5.  Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  M Fu; X Zhu; Q Wang; J Zhang; Q Song; H Zheng; W Ogawa; J Du; Y E Chen
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

6.  Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3.

Authors:  M Fu; J Zhang; X Zhu; D E Myles; T M Willson; X Liu; Y E Chen
Journal:  J Biol Chem       Date:  2001-10-05       Impact factor: 5.157

7.  Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

Authors:  A C Li; K K Brown; M J Silvestre; T M Willson; W Palinski; C K Glass
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

8.  Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus.

Authors:  M U Ehrengruber; S G Muhlebach; S Söhrman; C M Leutenegger; H A Lester; N Davidson
Journal:  Gene       Date:  2000-11-27       Impact factor: 3.688

9.  Expression and function of PPARgamma in rat and human vascular smooth muscle cells.

Authors:  R E Law; S Goetze; X P Xi; S Jackson; Y Kawano; L Demer; M C Fishbein; W P Meehan; W A Hsueh
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

10.  Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.

Authors:  Y Yamamura; X Hua; S Bergelson; H F Lodish
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

View more
  34 in total

1.  Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice.

Authors:  Kaizheng Gong; Yiu-Fai Chen; Peng Li; Jason A Lucas; Fadi G Hage; Qinglin Yang; Susan E Nozell; Suzanne Oparil; Dongqi Xing
Journal:  J Hypertens       Date:  2011-09       Impact factor: 4.844

2.  PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.

Authors:  Caiyan Zhao; Wei Chen; Liu Yang; Lihong Chen; Stephen A Stimpson; Anna Mae Diehl
Journal:  Biochem Biophys Res Commun       Date:  2006-09-22       Impact factor: 3.575

3.  Role of promoter DNA sequence variations on the binding of EGR1 transcription factor.

Authors:  David C Mikles; Brett J Schuchardt; Vikas Bhat; Caleb B McDonald; Amjad Farooq
Journal:  Arch Biochem Biophys       Date:  2014-03-18       Impact factor: 4.013

4.  Ciprofibrate regulation of rat hepatic bilirubin glucuronidation and UDP-glucuronosyltransferases expression.

Authors:  Jean-Marie Heydel; Philippe Garnier; Philippe Faure; Yves Artur
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-04-04       Impact factor: 2.441

5.  Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Yingze Zhang; Raju C Reddy
Journal:  FASEB J       Date:  2014-09-24       Impact factor: 5.191

6.  Arginine decreases peroxisome proliferator-activated receptor-γ activity via c-Jun.

Authors:  Kechen Ban; Zhanglong Peng; Wei Lin; Rosemary A Kozar
Journal:  Mol Cell Biochem       Date:  2011-10-26       Impact factor: 3.396

Review 7.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

8.  Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.

Authors:  Kaizheng Gong; Dongqi Xing; Peng Li; Baran Aksut; Namasivayam Ambalavanan; Qinglin Yang; Susan E Nozell; Suzanne Oparil; Yiu-Fai Chen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-16       Impact factor: 5.464

9.  Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro.

Authors:  Shizhong Zheng; Anping Chen
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

10.  Genetic variations in peroxisome proliferator-activated receptor gamma expression affect blood pressure.

Authors:  Yau-Sheng Tsai; Lonquan Xu; Oliver Smithies; Nobuyo Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.